Functional significance of adenosine 5′-diphosphate receptor (P2Y12) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibα induced by conditions of high shear rate

被引:104
作者
Goto, S
Tamura, N
Eto, K
Ikeda, Y
Handa, S
机构
[1] Tokai Univ, Sch Med, Dept Med, Div Cardiol, Kanagawa 2591193, Japan
[2] Keio Univ, Sch Med, Dept Med, Tokyo 160, Japan
关键词
platelets; thrombosis; glycoproteins; von Willebrand factor; receptors;
D O I
10.1161/01.CIR.0000016703.93845.AF
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The role of the adenosine 5'-diphosphate receptor P2Y(12) in platelet activation initiated by the von Willebrand factor (VWF)-GP Ibalpha interaction under high shear rate was investigated. Methods and Results-Blood samples were obtained from 11 donors. Shear-induced platelet aggregation was detected by optically modified cone-plate viscometer. Shear-induced VWF binding, P-selectin expression, and microparticle release were detected by flow cytometry. Platelet interaction with immobilized VWF was also investigated by parallel-plate flow chamber equipped with epifluorescent videomicroscopy. Effects of a selective P2Y(12) antagonist AR-C69931 MX were tested. AR-C69931 MX inhibited shear-induced platelet aggregation in a dose-dependent manner, achieving the maximum inhibition at 100 nmol/L. The extent of aggregation after exposure to a shear rate of 10 800 s(-1) for 6 minutes in the presence of 100 nmol/L AR-C69931 MX was 32.4+/-8.2% (mean+/-SD), which was significantly lower than the value in the controls of 69.7+/-9.6% (P < 0.01). The inhibiting effects of AR-C69931 MX were reversed by exogenous addition of adenosine 5'-diphosphate. Shear-induced VWF binding and P-selectin surface translocation, which occurred in 4696: 911 and 5964 784, respectively, of 10 000 measured platelets, was also inhibited by AR-C69931 MX (100 nmol/L) to 1948+/-528 and 2797+/-718, respectively (P = 0.0018 and P = 0.0009). Microparticle release was similarly inhibited. In a flow chamber experiment, firm platelet attachment on immobilized VWF was inhibited by AR-C69931 MX, whereas transient interaction was not influenced. All the above reactions were completely inhibited by blocking VWF-GP Ib alpha interaction. Conclusions-We have demonstrated that the stimulation of P2Y(12) is involved in platelet activation initiated by the binding of VWF to GP Ib alpha induced by a high shear rate.
引用
收藏
页码:2531 / 2536
页数:6
相关论文
共 33 条
[1]  
ALEVRIADOU BR, 1993, BLOOD, V81, P1263
[2]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[3]   PREVENTION OF OCCLUSIVE CORONARY-ARTERY THROMBOSIS BY A MURINE MONOCLONAL-ANTIBODY TO PORCINE VONWILLEBRAND-FACTOR [J].
BELLINGER, DA ;
NICHOLS, TC ;
READ, MS ;
REDDICK, RL ;
LAMB, MA ;
BRINKHOUS, KM ;
EVATT, BL ;
GRIGGS, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :8100-8104
[4]   ADP receptors and clinical bleeding disorders [J].
Cattaneo, M ;
Gachet, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2281-2285
[5]   SHEAR-INDUCED PLATELET-AGGREGATION IS POTENTIATED BY DESMOPRESSIN AND INHIBITED BY TICLOPIDINE [J].
CATTANEO, M ;
LOMBARDI, R ;
BETTEGA, D ;
LECCHI, A ;
MANNUCCI, PM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (03) :393-397
[6]  
Daniel JL, 1999, THROMB HAEMOSTASIS, V82, P1322
[7]   Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets [J].
Daniel, JL ;
Dangelmaier, C ;
Jin, JG ;
Ashby, B ;
Smith, JB ;
Kunapuli, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2024-2029
[8]  
Eto K, 2001, PLATELETS, V12, P228
[9]   Specific impairment of human platelet P2YAC ADP receptor-mediated signalling by the antiplatelet drug clopidogrel [J].
Geiger, J ;
Brich, J ;
Hönig-Liedl, P ;
Eigenthaler, M ;
Schanzenbächer, P ;
Herbert, JM ;
Walter, U .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) :2007-2011
[10]   A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].
Gent, M ;
Beaumont, D ;
Blanchard, J ;
Bousser, MG ;
Coffman, J ;
Easton, JD ;
Hampton, JR ;
Harker, LA ;
Janzon, L ;
Kusmierek, JJE ;
Panak, E ;
Roberts, RS ;
Shannon, JS ;
Sicurella, J ;
Tognoni, G ;
Topol, EJ ;
Verstraete, M ;
Warlow, C .
LANCET, 1996, 348 (9038) :1329-1339